Literature DB >> 25794720

Enzymatic production of HMO mimics by the sialylation of galacto-oligosaccharides.

Yuanming Wang1, Kai Jiang1, Huanna Ma1, Wei Zeng1, Peng G Wang2, Nana Yao3, Weiqing Han1, Jiansong Cheng4, Wei Wang3.   

Abstract

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycans that exhibit a wide range of biological activities. In this report, we describe an efficient, Multi-Enzyme One-Pot strategy to produce HMO mimics by the sialylation of galacto-oligosaccharides (GOSs), which are often added to infant formula as an inexpensive alternative to HMOs. In this system, the sialyltransferase donor, cytidine-5'-monophospho-N-acetylneuraminic acid (CMP-Neu5Ac), was generated in situ using a CMP-sialic acid synthetase. The sialylated GOSs were obtained by one-step purification after digesting CMP using the alkaline phosphatase PhoA to cytidine and inorganic phosphate. Although the synthesized α2,3-, α2,6- and α2,3/8-sialyl-GOSs exhibit different sialylation levels and patterns, all of these mixtures can be fermented by Bifidobacterium longum subsp. infantis ATCC 15697 but not by Bifidobacterium adolescentis ATCC 15703. The sialidase NanH2, which is unique to the former strain, hydrolyzed all of the synthesized HMO mimics.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Galacto-oligosaccharides; Human milk oligosaccharides; Mimics; Prebiotics; Sialyltransferase

Mesh:

Substances:

Year:  2015        PMID: 25794720     DOI: 10.1016/j.foodchem.2015.02.064

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  2 in total

1.  In silico analysis of the human milk oligosaccharide glycome reveals key enzymes of their biosynthesis.

Authors:  Andrew G McDonald; Julien Mariethoz; Gavin P Davey; Frédérique Lisacek
Journal:  Sci Rep       Date:  2022-06-27       Impact factor: 4.996

Review 2.  Shaping the Infant Microbiome With Non-digestible Carbohydrates.

Authors:  Stella Verkhnyatskaya; Michela Ferrari; Paul de Vos; Marthe T C Walvoort
Journal:  Front Microbiol       Date:  2019-02-25       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.